acarbose

(redirected from Glucobay)
Also found in: Medical.

ac·ar·bose

 (ăk′är-bōs′)
n.
A drug, C25H43NO18, that reduces blood glucose levels by inhibiting the breakdown of complex carbohydrates in the intestine and is used to treat type 2 diabetes.

acarbose

(eɪˈkɑːbəʊs)
n
a type of diabetes medicine taken orally to slow and reduce the supply of glucose to the blood.
Translations

acarbose

n acarbosa
References in periodicals archive ?
The intestinal alpha-glucosidase inhibitor acarbose (Glucobay; Bayer, Leverkusen, Germany) hampers the digestion of carbohydrates, lowers postprandial hyperglycemia and, secondarily, hyperinsulinemia, whereas the risk of hypoglycemia is low.
Starch was purchased from Sigma Life Science (Walthem, MA, USA) Acarbose (Glucobay A(r)) was obtained from Bayer AG (Wuppertal, Germany).
Distilled water, Starch, Acarbose tablets (Glucobay 500, Bayer), Haemoglobin (HIMEDIA Laboratories Pvt.
Acarbose from GlucoBay (50 mg) brand, Bayer Schering Pharma, was purchased from the market.
Bayer also recorded substantial sales increases for its diabetes treatment Glucobay (Fx adj.: plus 14.6 percent), its Aspirin Cardio product for the secondary prevention of heart attacks (Fx adj.: plus 13.8 percent) and its X-ray contrast agent Ultravist (Fx adj.: plus 18.0 percent), primarily as a result of the positive development of business in China.
The German-based chemical and pharmaceutical company Bayer started producing drugs in China since 1997 and particularly focusing on Glucobay which represents China's best-selling diabetes medicine (38).